Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

G-BA Innovation Committee announced funding of 18 new projects in Germany

On April 4, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced funding from the G-BA Innovation Fund for 18 innovative healthcare research projects dedicated to medical guidelines.

In this cycle, 31 applications were received, and the selection was made based on the recommendations from the pool of experts and the Working Group of Scientific Medical Societies (AWMF). The selected projects are divided into the following way:

  • Healthcare in rare diseases: 4;
  • Healthcare in more common diseases, treatment of risk factors for non-communicable diseases, multimorbidity and improvement of drug therapy safety in healthcare: 8;
  • Healthcare for target groups with special needs, such as children, young people, the elderly, and/or people in need of care: 5;
  • Surgical interventions on the skeletal system/locomotor system: 1.

The overview of the new projects is expected to be published on the Innovation Committee's website in May 2022.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.